These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
473 related articles for article (PubMed ID: 14520364)
1. Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Feldmann M; Maini RN Nat Med; 2003 Oct; 9(10):1245-50. PubMed ID: 14520364 [No Abstract] [Full Text] [Related]
2. [TNF inhibitors: a new therapeutic perspective in chronic inflammatory diseases in rheumatology?]. Fenner H Z Rheumatol; 1995; 54(3):158-64. PubMed ID: 7660686 [TBL] [Abstract][Full Text] [Related]
3. The possible role of tumor necrosis factor (TNF) and its natural inhibitors, the soluble-TNF receptors, in autoimmune diseases. Aderka D; Engelmann H; Wysenbeek AJ; Levo Y Isr J Med Sci; 1992 Feb; 28(2):126-30. PubMed ID: 1313788 [No Abstract] [Full Text] [Related]
4. The role of tumor necrosis factor in health and disease. Beutler BA J Rheumatol Suppl; 1999 May; 57():16-21. PubMed ID: 10328138 [TBL] [Abstract][Full Text] [Related]
5. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases. Williams RO; Paleolog E; Feldmann M Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887 [TBL] [Abstract][Full Text] [Related]
6. [New strategies in the immunotherapy of autoimmune diseases]. Lorenz HM; Geiler T Dtsch Med Wochenschr; 2001 Sep; 126(37):1023-8. PubMed ID: 11555778 [No Abstract] [Full Text] [Related]
7. TNF receptor fusion protein in rheumatoid arthritis. O'Brien C Mol Med Today; 1996 Jul; 2(7):269. PubMed ID: 8796900 [No Abstract] [Full Text] [Related]
8. Setting the cytokine trap for autoimmunity. Dinarello CA Nat Med; 2003 Jan; 9(1):20-2. PubMed ID: 12514715 [No Abstract] [Full Text] [Related]
9. Neuroendocrine modulation induced by selective blockade of TNF-alpha in rheumatoid arthritis. di Comite G; Marinosci A; Di Matteo P; Manfredi A; Rovere-Querini P; Baldissera E; Aiello P; Corti A; Sabbadini MG Ann N Y Acad Sci; 2006 Jun; 1069():428-37. PubMed ID: 16855170 [TBL] [Abstract][Full Text] [Related]
15. Anti-TNF therapy: where have we got to in 2005? Feldmann M; Brennan FM; Foxwell BM; Taylor PC; Williams RO; Maini RN J Autoimmun; 2005; 25 Suppl():26-8. PubMed ID: 16260118 [TBL] [Abstract][Full Text] [Related]
16. Circulating tumour necrosis factor-alpha bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response. Marotte H; Maslinski W; Miossec P Arthritis Res Ther; 2005; 7(1):R149-55. PubMed ID: 15642135 [TBL] [Abstract][Full Text] [Related]
17. Lasker Basic Medical Research Award. The eukaryotic transcriptional machinery: complexities and mechanisms unforeseen. Roeder RG Nat Med; 2003 Oct; 9(10):1239-44. PubMed ID: 14520363 [No Abstract] [Full Text] [Related]
18. Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease? Feldmann M; Brennan FM; Paleolog E; Cope A; Taylor P; Williams R; Woody J; Maini RN Novartis Found Symp; 2004; 256():53-69; discussion 69-73, 106-11, 266-9. PubMed ID: 15027483 [TBL] [Abstract][Full Text] [Related]
19. [Significance of tumor necrosis factor (TNF-alpha) in rheumatoid arthritis]. Godyń-Swedzioł RM; Stańczyk J; Hilt J; Kowalski ML Przegl Lek; 2004; 61(2):90-3. PubMed ID: 15230148 [TBL] [Abstract][Full Text] [Related]
20. TNF-blocking therapies: an alternative mode of action? Choo-Kang BS; Hutchison S; Nickdel MB; Bundick RV; Leishman AJ; Brewer JM; McInnes IB; Garside P Trends Immunol; 2005 Oct; 26(10):518-22. PubMed ID: 16087401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]